Supreme Court Decision
Two years after the US Supreme Court canceled the nationwide assurance to an abortion, it has unanimously upheld access to the abortion pill mifepristone, against the challenge of a group of anti-abortion doctors and activists. A decision welcomed by the pro-choice activists. According to the justices, the plaintiffs did not have a legal right to sue, although they left the door open for future attempts to limit the drug’s availability.
Background of the Case
Mifepristone, one of two drugs used in medication abortions, is the most common method of terminating pregnancies in the US. The plaintiffs, known as the Alliance for Hippocratic Medicine, argued that the US Food and Drug Administration (FDA) should withdraw its approval of the drug. However, during arguments, several justices expressed scepticism, saying that the plaintiffs would have a legal standing to sue, if any of them had suffered harm from mifepristone.
Court’s Reasoning
Justice Brett Kavanaugh, writing for the court, stated that the plaintiffs had “failed to demonstrate” any actual injury. He explained that a plaintiff’s desire to make a drug less available for others does not establish standing to sue. The ruling does not affect state laws that have imposed restrictions on abortion. However, it ensures that abortion pills, such as mifepristone, remain available, allowing individuals in states with restrictive abortion laws to still access these medications as a means to circumvent the bans and terminate pregnancies.
Pro-Choice Reactions
Pro-choice activists celebrated the decision as a preservation of access to abortion pills, although they warned it was a qualified victory. Nancy Northup, president of the pro-choice Center for Reproductive Rights, emphasised that the attacks on abortion pills will continue, as they are critical in the post-Roe world. President Joe Biden echoed these sentiments, stating that the fight for reproductive freedom continues and highlighting the high stakes for women across America.
Anti-Abortion Response
Anti-abortion groups criticised the Supreme Court’s decision but indicated that their fight would persist. Katie Daniel, state policy director for Susan B. Anthony Pro-Life America, described the day as sad for those who value women’s health and unborn children’s lives. She reaffirmed their commitment to stopping mail-order abortion drugs.
Future Legal Battles
The ruling does not prevent future challenges to the FDA’s approval of mifepristone in other states. At least three states—Missouri, Kansas, and Idaho—have opposed the FDA’s approval of the drug in court. The ongoing legal battles reflect the deeply divided landscape of abortion rights in the US and the continued efforts to navigate and challenge these regulations.
Follow us on Socials: